Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Servatis to pay for agchem pollution of river

Brazilian company Servatis (Resende) is to cease production of several pesticide products as part of a deal following a river pollution incident, official news agency Agencia Brasil reports. It has signed an adjusted terms contract, committing to investing R$38 million (US$75 million) in response to an environmental fine. It was responsible for an “accident in which it released 8,000 litres of [endosulfan] insecticide into the Paraiba do Sul River four years ago”, Agencia Brasil reports. The funds will go into environmental research activities, including clean-up and remediation of the polluted river. The company has agreed to cease production of six insecticides, including endosulfan, and seven herbicides within five years. Servatis will switch its business towards biotechnology and pharmaceutical products, Agencia Brasil adds. The company was also the recipient of fines from the national health surveillance agency, the Anvisa, last year over lack of controls in the reprocessing of pesticides at the behest of BASF ( Agrow No 626, p 20).


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts